JSC "Farmak" (secondary packaging, quality control, batch release from bulk product of the manufacturer: Farmaten International S.A., Greece or quality control, primary and secondary packaging, batch release: Farmaten S.A., Greece)

The drug is intended for monotherapy in adults and children aged 10 years and older with highly active relapsing-remitting multiple sclerosis or with a rapidly progressive, severe course of the disease.

Dosage form: capsules, hard

ATC: L04AA27